May 29, 2012
Gilead Sciences to Present at Two Upcoming Investor Conferences
- Jefferies 2012 Global Healthcare Conference on June 5th
-
- Goldman Sachs 33rd
Annual Global Healthcare Conference on June 6th
-
- Webcasts Available Through Gilead Corporate
Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--May. 29, 2012--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company
will be webcasting its corporate presentation at two upcoming investor
conferences: the Jefferies Global Healthcare Conference in New York and
the Goldman Sachs Healthcare Conference in Rancho Palos Verdes,
California.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
and Robin Washington, Gilead’s Senior Vice President and Chief Financial
Officer, will provide an overview of the company at the Jefferies
conference on Tuesday, June 5 at 10:30 a.m. Eastern Time and the Goldman
Sachs conference on Wednesday, June 6 at 9:20 a.m. Pacific Time (12:20
p.m. Eastern Time).
To access the live webcasts via the Internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to
each live presentation to ensure adequate time for any software download
that may be necessary to listen to the webcast. The replay will be
available for 14 days following the presentation.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor
Relations)
